Robert Redfield III

The primary focus of Dr. Redfield’s research is to develop strategies that are safe and effective in preventing and reversing the production of detrimental donor specific antibody in transplant patients. Donor specific antibodies (DSA) are a significant barrier to kidney transplantation for sensitized patients and currently an absolute barrier for pancreas transplantation.